Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy, the semaglutide injection licensed in the UK for weight management, does not come as a syringe you fill yourself. It is supplied as a pre-filled, pre-set pen — a self-contained device you click, press and dispose of after each weekly dose. If you have searched for a semaglutide pre-filled syringe because you want to understand exactly what arrives and how it works, this page covers the format in full, including how the device is used, what the licensed strengths look like in practice, and what the pre-filled design means for you day to day. Wegovy is a prescription-only medicine; a prescriber assesses whether it is appropriate before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people searching for a semaglutide pre-filled syringe are trying to picture something practical: what will I actually hold, what do I do with it, and is it as complicated as it sounds? That is a reasonable question to start with, because the format of the device shapes almost everything about the day-to-day experience of treatment.
Wegovy does not use a conventional syringe that you would draw medication into from a vial. Novo Nordisk supplies it as a pre-filled auto-injection pen with the semaglutide solution already inside. You dial nothing. You measure nothing. The pen is set at one fixed dose for that particular strength, and once you have selected your injection site (abdomen, outer thigh or upper arm) you press the pen against the skin and activate it. The NHS medicines guidance on semaglutide describes the device as a single-use, pre-set pen, and that is the most accurate short description.
For most people, this simplicity is the point. There is no risk of drawing the wrong volume, no need to handle loose needles, and no glass vials to manage. The broader picture of semaglutide treatment covers the clinical side; this page stays with the device itself. One quick check you can do before your first injection: hold the pen up to the light and confirm the solution looks clear and colourless, with no visible particles, it takes under a minute and is the standard recommendation in the Patient Information Leaflet.
Semaglutide for weight management follows a titration pathway. Treatment begins at 0.25 mg once weekly, a starting dose our guide to the .25 semaglutide syringe covers in detail, and moves through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, typically over around four months. Each step uses a different pre-filled pen, already set to that strength. The MHRA approved a 7.2 mg single-dose pen in April 2026 for adults with a BMI of 30 or above, giving prescribers a higher maintenance option; that pen works on the same pre-filled principle, with a built-in covered needle that locks automatically after use.
Because each pen comes pre-set, moving between dose strengths does not require any adjustment on your part. Your prescriber reviews your progress and changes the prescription; the next pen simply arrives at the new strength. There is nothing to recalibrate.
If you are thinking about what size of pen or needle suits you, our guide to the semaglutide pre-filled syringe explains the physical dimensions of the devices across the dose range, useful if you are comparing formats or have dexterity considerations. Separately, some patients ask whether the timing of weekly injections can be adjusted slightly; the answer on timing flexibility covers what the guidance says. A prescriber makes the final call on your specific schedule, and the Wegovy treatment overview explains the full clinical picture, including eligibility and what to expect across the course.
The pre-filled design is not just convenient, it carries genuine safety advantages that matter for a medicine used weekly at home, unsupervised. Because the dose is factory-set and the needle is integral to the device, there is no opportunity for dosing errors from incorrect measurement, contamination from reused needles or accidents with loose sharps.
The NHS notes that semaglutide injections should be given once a week, on the same day each week if possible, and that if a dose is missed the guidance in the NHS semaglutide patient information or the leaflet inside the pack should be followed. This is particularly important: missed-dose decisions are covered by the Patient Information Leaflet and your prescriber, not by general online advice.
For patients who want to understand how Wegovy compares on this practical dimension (including cost across the dose range) the Wegovy pricing guide sets out the context honestly, including what a legitimate private prescription covers. One thing worth knowing: the price you pay through a regulated pharmacy includes clinical oversight, not just the pen itself. A prescription from a GPhC-registered service means a real clinician has reviewed your health information before anything is dispensed. You can verify any online pharmacy on the GPhC register in moments, the registration number is the simplest trust check available.
The pre-filled pen format removes most of the practical barriers people worry about before starting a weekly injection. The injection itself is subcutaneous (just under the skin) and the needle is short and fine. Most patients report that the initial anxiety about self-injecting fades quickly once the first dose is done.
The bigger decision is clinical, and that is where a prescriber's input is irreplaceable. Wegovy is licensed for adults with a BMI of 30 or above, or 27 and above alongside a weight-related condition such as high blood pressure or raised cholesterol; lower thresholds apply for some ethnic backgrounds under UK guidance. The NICE appraisal of semaglutide for weight management, NICE TA875, sets out the clinical criteria in full. A prescriber considers your full health picture, not just your BMI.
If you would like to explore whether semaglutide treatment is appropriate for your situation, our prescribers review consultations the same day, a real clinician, not an automated system. You can also read about the range of weight-loss treatments available, or look at how nume works before making any decision. There is no pressure and no commitment at the consultation stage.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.